USD 7.04
(1.15%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 46 Thousand USD | -98.95% |
2022 | 4.36 Million USD | 29.8% |
2021 | 3.36 Million USD | 22.88% |
2020 | 2.73 Million USD | 0.0% |
2019 | - USD | 0.0% |
2001 | 4.36 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | -100.0% |
2024 Q1 | 1.00 USD | -100.0% |
2023 FY | 46 Thousand USD | -98.95% |
2023 Q4 | 46 Thousand USD | -34.29% |
2023 Q2 | 391 Thousand USD | -84.42% |
2023 Q1 | 2.5 Million USD | -42.51% |
2023 Q3 | 70 Thousand USD | -82.1% |
2022 Q4 | 4.36 Million USD | -25.53% |
2022 Q3 | 5.86 Million USD | -27.67% |
2022 Q2 | 8.1 Million USD | -6.84% |
2022 FY | 4.36 Million USD | 29.8% |
2022 Q1 | 8.69 Million USD | 158.69% |
2021 Q1 | 3.41 Million USD | 24.89% |
2021 FY | 3.36 Million USD | 22.88% |
2021 Q4 | 3.36 Million USD | -3.22% |
2021 Q3 | 3.47 Million USD | 27.91% |
2021 Q2 | 2.71 Million USD | -20.52% |
2020 FY | 2.73 Million USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 2.73 Million USD | 0.0% |
2019 FY | - USD | 0.0% |
2001 FY | 4.36 Million USD | 0.0% |
2001 Q4 | 3.36 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ADC Therapeutics SA | 16.17 Million USD | 99.716% |
Alto Neuroscience, Inc. | - USD | -Infinity% |
Annovis Bio, Inc. | - USD | -Infinity% |
Biohaven Pharmaceutical Holding Company Ltd. | - USD | -Infinity% |
Nuvation Bio Inc. | - USD | -Infinity% |
Nuvation Bio Inc. | - USD | -Infinity% |
Arcus Biosciences, Inc. | - USD | -Infinity% |
Zymeworks Inc. | 1.00 USD | -4599900.0% |